Prandin

Product NDC
0169-0081
11-digit product format
001690081
Labeler code
0169
Product ID
0169-0081_814078bb-8c13-a996-e053-2991aa0ab042
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
repaglinide
Dosage form
TABLET
Route
ORAL
Labeler
Novo Nordisk
Application
NDA020741
Marketing category
NDA
Marketing start
2000-01-03
Marketing end
2020-10-31
Substance
REPAGLINIDE
Active strength
1 mg/1
Pharmacologic classes
Glinide [EPC],Potassium Channel Antagonists [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ea03026f-270e-3aaa-c14e-f7103b55f75bProduct name320240321
85cbb42f-1a8d-f945-f85e-188e823b7f5bProduct name220150731

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0169-0081-81EA - Each0169-0081b022d1e9-d530-48e8-8a70-179c8b29934512012-07-24
0169-0081-83EA - Each0169-0081979d1a24-27db-4a3a-b9b0-dee6fe0114a612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
REPAGLINIDEACTIVE INGREDIENT668Z8C33LUPRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT]2
REPAGLINIDEACTIVE MOIETY668Z8C33LUPRANDIN (REPAGLINIDE) TABLET [CARILION MATERIALS MANAGEMENT]2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
213218Prandin 0.5 MG Oral TabletPSN813f781f-7db8-49ed-b4ed-a829c37eddb75
200257repaglinide 0.5 MG Oral TabletPSN813f781f-7db8-49ed-b4ed-a829c37eddb75
213218repaglinide 0.5 MG Oral Tablet [Prandin]SBD813f781f-7db8-49ed-b4ed-a829c37eddb75
200257repaglinide 0.5 MG Oral TabletSCD813f781f-7db8-49ed-b4ed-a829c37eddb75
213218Prandin 0.5 MG Oral TabletSY813f781f-7db8-49ed-b4ed-a829c37eddb75